The milky spots of the peritoneum and pleura: structure, development and pathology by Michailova, Krassimira N. & Usunoff, Kamen G.
Founded and printed in Varna, Bulgar ia
ISSN 1310-392X
Biomedical Reviews 2004; 15: 47-66.
THE MILKY SPOTS OF THE PERITONEUM AND PLEURA:  
STRUCTURE, DEVELOPMENT AND PATHOLOGY
Krassimira N. Michailova and Kamen G. Usunoff 
Department of Anatomy and Histology, Faculty of Medicine, Medical University, Sofia, Bulgaria
The milky spots (MS), originally described by Ranvier as taches laiteuses, are found on the greater omentum but also in other 
peritoneal regions, as well as on the pleura and pericardium. They represent aggregations of mesenchymal tissue surrounding blood 
vessels. These small whitish regions are covered by mesothelium, and within the mesothelial layer are scattered macrophage-like 
cells. The blood supply of MS is provided by arterioles that give rise to capillary network formed by fenestrated or continuous 
endothelial cells. Most MS possess also lymphatic vessels, with extremely thin endothelial cells. The most frequent cells in MS 
are the macrophages, followed by lymphocytes and mast cells. Typically, the macrophages are located in the periphery, while the 
lymphocytes - in the center of MS. Additional structural elements are plasmocytes, adipocytes, fibroblasts, rounded fibroblast-like
cells (undifferentiated mesenchymal cells), as well as collagen, reticular and elastic fibers. The nerve fibers innervating MS are
located under the mesothelium and among the free cells. Despite their small size, the MS are a significant organ, functioning at
both normal and pathological conditions. Under inflammatory conditions (peritonitis), MS act as the first line of defense, and
dramatically change their number, size and structure. MS are also involved in extramedullary hemopoiesis. They are the first
target of intraperitoneal (intrapleural) metastases, and appear an important target in the development of immunotherapeutic 
strategies against malignant diseases. 
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INTRODUCTION
It is a traditional belief that von Recklinghausen (1) first re-
ferred to the macroscopically visible whitish spots in the omen-
tum of young rabbits, but this statement might not be precise 
because he described the so-called “stomata” on the abdominal 
surface of the diaphragm, and has not investigated the greater 
omentum (2). The spots were first recognized by Ranvier (3),
and he named them taches laiteuses, i.e. milky spots (MS). 
Ranvier considered the greater omentum as a giant, flattened
lymph node, the lymph sinus of which is represented by the 
peritoneal cavity. These tiny accumulations of lymphoid tissue 
were soon recognized to have a protective role, and Morrison 
(4) with sympathy called the greater omentum “policeman of 
the abdomen”; it has also been designated “friend in need” 
and “the great leucocyte” (2,5). MS were identified in a wide
variety of species: mice (6-8), rats (6-13), guinea pigs (6, 10, 
14), rabbits (1,6,15), pigs (6,16), sheeps and goats (17), and 
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cats (15). Although described in 1921 in the human greater 
omentum (18), and despite the great biological importance, 
there are relatively few investigations on human MS until 
now. In the human omentum, MS are difficult to identify
because they are very small compared with lymph nodes and 
are usually embedded in adipose tissue, particularly in older 
subjects (19). Human MS are larger (0.5-3.5 mm2), while 
in the laboratory animals they are typically of smaller size 
(0.1-3 mm2) (2).
 According to the present knowledge, the MS are implicated 
in several important biological functions. They represent a 
major immune organ in the peritoneal cavity (5,8,19-26). 
Further, MS produce and provide free peritoneal cells, such 
as macrophages/monocytes and lymphocytes (11,12,26-31). 
Under inflammatory conditions, MS increase their number and
size and act as the first line of defense in the peritoneal cavity
(11,12,32-34). The MS are a major gate through which circu-
lating inflammatory cells migrate from omental vessels into
the peritoneal cavity (11,12,28,29). They play an important 
role in scavenging foreign substances in the peritoneal cavity 
(28, 35,36). The MS participate in the formation of ascites 
by filtering fluid from the capillaries to the peritoneal cavity
(29,37). They are involved in extramedullary hematopoiesis 
(8,31,34,38,39). Along the “ordinary” peritoneal mesothelium 
(40,41), MS are greatly altered by continuous peritoneal di-
alysis (42-46). 
 We here present an updated review on the structure, de-
velopment and function of MS, their involvement in differ-
ent pathological processes, and add our results on the blood 
supply and ultrastructure of MS in humans and experimental 
animals.
STRUCTURE AND FUNCTION OF THE MILKY SPOTS IN THE 
GREATER OMENTUM
As pointed out in the Introduction, Ranvier (3) considered 
the MS as a large, disseminated lymph node. At that time the 
structure of the lymph node was known, and that statement 
was repeatedly appreciated (47-50). However, Milian (51) 
declared that in the MS there are numerous phagocytic cells, 
and Seifert (52) first differentiated the MS from the lymphatic
nodes, considering the MS as a part of the reticuloendothelial 
system. They were reasonably named “a lymphoreticular 
organ” (53).
 Omental MS consist of mesenchymal cells surrounding 
blood vessels (2,19). Silver impregnation shows the delicate 
networks of reticular fibers which constitute the framework
of the organ (33). The blood supply is received from the epi-
ploic branches of right and left gastroepiploic (gastroomental) 
arteries. The microvasculature of MS consists of a classic 
succession of arteriole, precapillary, capillary, postcapillary, 
collecting venule, and venule (19,54,55). Shunt vessels were 
also observed in the omental nodules (15,56,57). The small 
vessels in the MS are nominated “omental glomeruli” (58). 
The drainage veins of MS enter the epiploic branches of gas-
troepiploic veins to the portal venous system via the superior 
mesenteric and splenic veins (2,19). Most MS capillaries are 
fenestrated (8,9,17,29,37,59), in contrast to other capillaries 
in the omentum which have non-fenestrated endothelium (9). 
The side pressure in the twisted MS capillaries is increased 
according to the law of Bernoulli due to the slow velocity of 
the bloodstream (60). In inflammation, when the capillaries
become hyperemic, the fenestration of the endothelium and 
the higher pressure enhance the cell penetration from the 
capillaries in the interstitial spaces. In the thin parts of the 
omentum, also non-vascularized MS are observed (59,61,62). 
These small, flat lymphoid aggregations are scattered within
the omental membrane, and their cell composition is similar 
to that of vascularized MS except for the absence of neurtro-
philic myelopoiesis. The non-vascularized MS increase their 
number and size in peritonitis, and therefore they might rep-
resent secondary formations that are composed primarily of 
macrophages and derived from the “ordinary” MS (59).
 Casparis (63) first demonstrated unequivocally the lym-
phatic vessels of the greater omentum, and his results were 
confirmed repeatedly (54,64-66). There are certain species
differences in the MS lymph vessels (66). In rats and guinea 
pigs, they form plexiform arrangements, whilst in rabbits and 
dogs the lymph vessels are larger, less plexiform and distend 
in some regions. Injection of Georta blue dye in human MS 
demonstrated lymphatic capillaries with blind ends (54). The 
diameter of dilated capillaries exceeds 150 µm. They are 
superficial, close to the mesothelial cells, emerge from MS
and empty in the efferent lymphatic vessels. Thus, they may 
participate in the absorption of various substances from the 
peritoneal cavity (54). Blind endothelial sacculations of the 
terminal lymphatics that drain in collecting channels have also 
been described (67). The ultrastructural data suggest that the 
initial lymphatics in the MS open into the peritoneal cavity 
because the endothelial cells of lymphatics mesh with the 
connective tissue mesothelial cells (19).
 We examined the blood supply of the omental MS in rabbits 
following injection of India ink in the most proximal portion 
of the abdominal aorta. The networks of vessels within MS are 
seen with ovoid, round or irregular form (Fig. 1a,b). Typically, 
two arterioles supply a single MS (Fig. 1a), and more rarely 
these are 3-5 arterioles (Fig. 1b). The afferent arterioles most 
           
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commonly divide dichotomously, and from these branches a 
capillary network is formed. The capillaries display dilated 
portions located in the central zones of MS, and have a mark-
edly convoluted course with numerous anastomoses. Four 
types of capillary formations can be distinguished: intramem-
branous type, sessile marginal type, pedunculated type, and 
less vascularized type (68). Following this classification, we
observed only occasional cases of the pedunculated type.
 On Fig. 1c-e, we present electron micrographs from rat 
omental MS. The main vascular structures are the blood cap-
illaries, whilst the lymph capillaries are scant, and we often 
observed MS without lymphatics. MS are covered by a thin 
mesothelium (Fig. 1c). The mesothelial cells display numer-
ous fine evaginations, filled with microvesicles and groups of
mitochondria. The endothelial cells of the blood capillaries 
are electron-dense, unlike the electron-lucent endothelial 
cells of the remaining parts of the omentum. The capillaries 
are of continuous type (Fig. 1d) and the endothelial cells are 
surrounded by a basal lamina. The endothelial cells show an 
extensive caveolar system, suggesting a vigorous transen-
dothelial transport. Notably, we encountered relatively few 
fenestrated capillaries. The lymphatic capillaries (Fig. 1e) 
display rounded lumen, and the thin endothelial cells are 
electron-lucent without basal lamina. 
 Early observations suggested that the mesothelial covering 
of MS is discontinuous (47,69), which was later confirmed
(7,9,11,26,53,70-73). Inbetween the mesothelial cells, there 
are rounded openings with diameter of 1-10 µm (11,26,71,72). 
Figure 1. Networks of vessels within the rabbit omental milky spots (MS) revealed by injection of Indian ink in the abdominal 
aorta (a, b). a: Two main arterioles (large arrows) supply a single MS. Capillaries with markedly convoluted course. The 
anastomoses are labeled with small arrows. b: Three arterioles (large arrows) form a capillary network with dilated portions 
(small arrows) in the center of MS. Electron microscopic from rat omental MS (c-e). c: Evaginations and invaginations of 
the thin activated mesothelium over two blood capillaries (asterisks). The endothelial cells are electron-dense and filled
with microvesicles. d: Neutrophil leukocyte (large arrow) in vicinity of a blood capillary (Bc) with continuous endothelium 
over a basal lamina (small arrows). e: Thinnings of the endothelial cells surround the round lumen of a lymph capillary 
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These are designated "gaps", "crypts", and most often "sto-
mata". Stomata are also seen in the mesothelial covering on 
the both sides of the diaphragm, the anterior abdominal wall, 
the liver, and the lower portions of the costal pleura (74-77). 
The lack of basal lamina under the mesothelial cells of MS 
fascilitates cellular migration (9,11,26,29,53,70). On scanning 
electron microscopy, the surface of MS appears morphologi-
cally distinct from the surface of the other omental regions 
because of its typical cobblestone appearance (26). Most of 
the mesothelial cells are dome-shaped and feature longer and 
more numerous microvilli on the apical surface than those of 
the thin transparent regions of the omentum.
 The cellular composition of MS was studied intensively. 
The “active” MS (52) contain numerous lymphoreticular 
cell elements located in the deep portion of the spot or su-
perficially (2). The most numerous are the macrophages and
lymphocytes, less numerous are macrophages with dendrites 
and plasmocytes. Close to the capillaries are located numerous 
periadventitial cells. Undifferentiated mesenchymal cells and 
fibroblasts can also be found (2,9,19,53,70,78,79).
 Macrophages are the most numerous (30-48%) cellular 
components of MS (11,12,19,23,80). In infants with healthy 
peritoneum (operated for neuroblastoma), the mean number 
of macrophages per MS is 570 ± 33, of which 47.5 ± 7.5% 
are immunohistochemically stained by the macrophage-
specific monoclonal antibody Leu-M5 (CD11c) (19, 23).
In fact, the proportion of such macrophages in the human 
omental MS might be even higher: 67.9 ± 9.4% (81). In rats, 
the MS of the greater omentum can be seen macroscopically 
as early as 30 min after injection of carbon particles (82). In 
humans, the omental MS were stained black when a carbon 
suspension was inadvertently injected in the peritoneal cavity 
(19,83,84). On the surface of MS, the mesothelial cells which 
line the peritoneal cavity are often replaced by macrophages 
(7,9,26,49,53,73). In some instances, these macrophages form 
two-three layers and orient toward the peritoneal cavity for 
trapping or permitting the entrance of foreign particles (19). 
As referred above, the mesothelial stomata and the lack of a 
basal lamina provide suitable environment for the cells within 
MS to migrate from the interstitial spaces into the peritoneal 
cavity, or vice versa. Several studies focused on the origin of 
the MS macrophages (11,12,83-87). Two types of peritoneal 
macrophages were described on the basis of their origin (87). 
Under normal conditions, peritoneal resident macrophages 
derive from locally proliferating progenitor cells in MS, which 
themselves have a bone marrow origin. However, in inflamma-
tory conditions, most peritoneal macrophages directly derive 
from monocytes produced in the bone marrow. An alternative 
classification based on peroxidase activity patterns has also
been proposed (11,12), dividing MS macrophages into three 
types: exudate macrophages (monocytes), exudate-resident 
macrophages, and resident macrophages. At steady state, the 
majority (>90%) macrophages are resident macrophages local-
ized peripherally in MS. Exudate macrophages or monocytes 
increase their number and develop into exudate-resident and 
resident macrophages. Interestingly, under inflammatory
conditions, even promonocytes are localized perivascularly 
in MS. 
 By using ummunostaining for macrophage precursor anti-
gens, it was demonstrated that MS play an important role in 
the origin of peritoneal macrophages (30). Early macrophage 
precursor antigens ER-MP12 and ER-MP58 were detected 
only on cells localized inside MS. On the other hand, an antigen 
which disappears late in the course of macrophage differentia-
tion, ER-MP20, was detected in high amounts on cells both 
inside and around MS. Thus, the macrophage precursors have 
central localization within MS, while more differentiated cells 
are found more peripherally (30). MS possess a microenviron-
ment in which precursor cells of the mononuclear phagocyte 
system can home and proliferate, and MS is a local source of 
free peritoneal macrophage generation. To elucidate the differ-
entiation mechanisms of macrophages in the murine omentum, 
Zhu et al (88) studied the repopulation of these cells and the 
expression of macrophage colony-stimulating factor (MCSF) 
in MS and omental tissues of mice depleted in macrophages 
following administration of clodronate. The macrophages in 
the omentum were spindle or dendritic in shape and phagocy-
tized intraperitoneally injected carbon particles. Macrophages 
and their precursors were detected in MS, and the number of 
precursors increased after the elimination of macrophages. 
The macrophage precursors in the MS proliferated, moved to 
the omentum, and transformed into dendritic-shaped macro-
phages. The locally produced MCSF might play an important 
role in providing a microenvironment for development and 
differentiation of omental macrophages (88).
 The immunological importance of the omental MS was 
recognized long ago (89). They were considered to be highly 
analogous to regional lymph nodes (19,73,84). Lymphocytes 
are the second major cellular component of normal MS, with 
B lymphocytes representing 29.1 ± 5.2% and T lymphocytes 
representing 11.7 ± 2.4% of the cells in MS (19,23); another 
study reports that B lymphocytes comprise 10.1 ± 3.4%, and 
T lymphocytes - 10.2% ± 3.7% (81). Macrophages covering 
the MS facing the peritoneal cavity trap and digest the circulat-
ing antigens and foreign bodies. The macrophages may then 
transfer information to lymphocytes in the central part of MS 
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tin (8). Mitotic figures in the immature neutrophil leukocytes
were also noticed. Myeloblast-like cells or undetermined 
hematopoietic cells that have a lymphoid cell appearance 
are rarely admixed with lymphocytes. Interestingly, mega-
karyocytes were also found; these could be cells that did not 
directly migrate in MS from other hematopoietic organs (8). 
Megakaryocytic precursor cells, or stem cells, which might 
have migrated into MS from the bone marrow or spleen, might 
differentiate and develop into mature megakaryocytes. Such 
active hematopoiesis in the MS of NZB mice could be related 
to an increased stem cell activity (93). Similar results were 
reported in the activated omental MS of normal mice (34). 
The authors encountered a myeloid compartment, composed 
of immature and mature cells of monocyte/macrophage, neu-
trophil, eosinophil and megakaryocytic lineages. Thus, MS 
appear to be mixed lymphoid organs, with secondary and/or 
primary lymphoid organ function, being an important site of 
B1 cell generation, plasma cell maturation and extramedullar 
hematopoiesis (34). There is a general consesus that MS in 
humans and normal animals do not display an erythropoietic 
ability. After injections of erythropoietin in the peritoneal 
cavity of ddY mice, small clusters of erythroblasts in various 
maturation stages were observed, including dividing erythro-
blasts, denucleating erythroblasts and reticulocytes (39). Thus, 
MS appear to have a latent erythropoietic activity.
 With respect to the nature of omental MS, an interesting 
possibility has been raised that they might represent an intesti-
nal thymus (76). Thus, omental lymphatic tissues constitute a 
discrete lymphatic unit that is closely connected to the spleen 
and the lymph nodes developing around the splenic vessels. 
However, this possibility has been questioned (8), since there 
is no relation between the thymus and MS from anatomical 
and histological points of view. Nevertheless, omental MS 
may be splenoid lymphoid tissues (8).
 As a rule, the MS are associated with adipose tissue 
(2,6,9,11,18,19). The adipocytes associated with the lymphoid 
tissues have special properties that distinguish them from clas-
sical adipocytes. Lymphoid cells and adipocytes interact in a 
paracrine manner, which is particularly evident in activated 
MS and lymph nodes (94-99). MS adipocytes contribute little 
to whole-body energy supply during fasting, but are more 
sensitive than all others to cytokines and norepinephrine, 
having higher maximum but lower minimum rates of lipolysis 
(100).
 MS receive innervation. Human omental arteries and veins 
are supplied by nerve fibers containing norepinephrine and
neuropeptide tyrosine (NPY) (101). Human MS also contain 
NPY, and its release from perivascular sympathetic fibers
(73,84). Dux et al (90) studied the lymphocytes in the mouse 
MS after intraperitoneal injection of sheep erythrocytes. The 
MS contain surface immunoglobulin-positive B lymphocytes, 
and T lymphocytes: helper and cytotoxic types. After second-
ary antigen challenge, the number of lymphocytes increases. 
The B and T lymphocytes segregate: the B cell zone is in the 
periphery, resembling the primary follicles of a lymph node, 
whilst the T lymphocytes are to be found centrally, resembling 
the paracortex of a lymph node. Other researchers considered 
that the lymph vessels emanating from MS may correspond 
to the efferent lymph vessels of the lymph nodes (19). On 
the other hand, it was stressed that the omental MS in mice 
are mainly supplied by blood vessels, and are largely devoid 
of lymphatic vessels, so that they seem to be different from 
lymph nodes (8). It was repeatedly considered that the omental 
MS take part in the humoral defense of the host response to 
intraperitoneal "vaccination" (19,89-92). The majority of the 
antibody-containing cells are localized predominantly in MS 
following injections of antigen (91). After intraperitoneal stim-
ulation using sodium thyoglycolate, China ink, and typhoid 
vaccine, Mandache et al (92) have shown the appearance of 
lymphatic follicles, some of them being with germinal centers. 
They thus stated that omental MS are subsidiary secondary 
lymphoid organs. The omental MS of healthy mice contain 
mainly IgM-positive B cells and lower numbers of CD23- and 
CD45R- positive B2 lymphocytes (34). The presence of mast 
cells in the MS was repeatedly noted (2,19,23,34,45,61,77-
79,93). Under normal conditions they are relatively few (19, 
23), but in pathological conditions their number increases (see 
below).
 MS are involved in extramedullary hematopoiesis, and 
some data on the macrophage generation were reviewed above. 
Omental MS in normal animals occasionally show neutrophilic 
myelopoiesis (8,38,59,62). Clear indication for a strong ex-
tramedullary hematopoiesis was repeatedly demonstrated in 
New Zealand Black (NZB) mice. However, this is not stan-
dart laboratory animal. It has especially large and numerous 
omental MS, and easily develops autoimmune diseases (8,93). 
The basic structure and cell composition of omental MS in 
NZB mice resemble those of normal mice (59,62), except for 
the presence of megakaryocytes and peculiar reticulum cells 
that possess well-developed dense bodies consisting of clus-
tered parallel tubules. Such MS contain numerous clusters of 
neutrophils at various maturation levels. Immature cells have 
been convincingly demonstrated with their electron-opaque 
cytoplasm, rounded cytoplasmic granules ranging from 0.1 to 
0.3 µm in diameter (primary granules), ring-shaped or slightly 
indented nuclei, prominent nucleoli, and fine nuclear chroma-
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may influence the local circulation (19). Interestingly, human
omental MS contain also dopamine-immunoreactive fibers
(102). Moreover, they were located not only perivascularly, 
but also throughout MS. A recent review of the peripheral 
dopaminergic system can be found in (103).
 We have investigated human omental MS, obtained after 
laparatomy from 15 patients of both sexes (9 males and 6 
females), aged 35-67 years. The omental regions without 
pathologic alterations (with continuous mesothelial cover-
ing, intact free cells and vessels in the submesothelial layer) 
were first identified on semithin sections (1 µm thick), and 
then examined on ultrathin sections by means of transmission 
electron microscopy (Fig. 2a-c). Unlike the rat, the human MS 
exhibited a rough surface, with ridges surrounded by deep fur-
rows. The latter displayed different shape, depth and width. 
The mesothelial covering was usually extremely thin (Fig. 
2a), but clusters of cubic cells were also encountered. Small 
groups or single phagocyte-like mesothelial cells were found. 
They had numerous pseudopod-like evaginations and abundant 
secondary lysosomes. In the normal omentum, stomata were 
only occasionally seen. A space between two neighbouring 
mesothelial cells was commonly observed but these are not 
true stomata. The typical interruptions of the mesothelial cov-
ering and its direct connection with underlying endothelium 
(stomata) were recognized only on serial ultrathin sections by 
means of transmission electron microscopy. In most cases, the 
mesothelial basal lamina is absent over MS. Most numerous 
from the free cell populations are the macrophages, followed 
by lymphocytes. We encountered fairly constant numbers 
of mast cells (Fig. 2b). Unlike the classical description of 
superficial macrophages and deeply located lymphocytes, we
most often observed that the cell populations are mixed. In 
Figure 2. Electron microscopic micrographs from human omental MS. a: Two lymphocytes (arrows) and blood capillary (Bc) 
under extremely thin mesothelial covering (empty arrows). b: Macrophages (arrows), mast cell (empty arrow) in vicinity of 
a blood capillary (asterisk). c: A lymphatic capillary (arrows) with a complicated contour. The parallel endothelial walls 




b c * *
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the mediastinal MS in mice by electron microscopy and im-
munohistochemistry (109). The spots are covered with plump 
mesothelial cells and consisted of clustered lymphocytes, 
macrophages and fibroblasts; lymphatics are not present in
these MS. They also show a specific distribution of lymphocyte
subsets: the T cell area comprises the basal region, adjacent 
to adipocytes under the lymphoid tissue, while the B cells 
are located superficially. Further studies on the pleural MS
(107,110,111) concentrated on their functional abilities. Ac-
cordingly, it was found that the anthracotic “black spots” of the 
parietal pleura and MS show light and electron microscopical 
similarities (111). Other investigators demonstrated highly 
vascularized MS on the human thoracic pleura (112). They 
have a mesothelial covering and are composed of lymphocytes, 
macrophages and plurivacuolated adipocytes. The existence 
of MS in the costal pleura was also confirmed (113), and MS
facing the pericardial cavity were described (114,115). They 
are composed of lymphocytes, macrophages and mast cells. 
In various rodents (rats, mice, golden hamsters), pores con-
nect the pericardial and pleural cavities, and frog erythrocytes 
injected in the pleural cavity are surrounded and phagocytosed 
by the pericardial macrophages as early as five minutes after
the injection. MS of the rabbit pericardium were studied and 
compared with MS of the mediastinal pleura and the omentum 
(116). Injection of India ink and latex particles in the pericar-
dial cavity lead to ingestion of the particles into macrophages, 
pericardial cavity, or submesothelial layer.
 The ultrastructural appearance of MS-like structures located 
in the deep portions of the broad ligament of the uterus (liga-
mentum latum uteri) is shown in Fig. 3a, b. The surface of the 
ligament forms large ridges with complex shape, limited by 
deep furrows, like those of the human greater omentum (Fig. 
3a). The majority of the mesothelial cells are from the flat cell
type. Small clusters of cubic cells are seen between the flat
cells. These MS-like structures are composed by macrophages, 
small groups of mast cells, adipocytes, neutrophils, lympho-
cytes and single erythrocytes. Fibroblasts, small bundles of 
collagen fibers and rare elastic fibers surrounded these cells.
Lymphatic vessels are more common than blood vessels. Small 
groups of blood capillaries and large cysterna-like lymphatic 
vessels with extremely flat lumina or with irregular boundar-
ies are located parallel to the peritoneal surface (Fig. 3b). The 
thin, electron-lucent lymphatic endothelium rests upon a fine,
incomplete basal lamina. The neighboring lymphatic vessels 
are separated by thin septae, and contain endothelial valve- or 
bridge-like formations. We observed different types of contacts 
between the extremely thin intercellular zones of cubic meso-
thelial cells and endothelial protrusions of lymphatic vessels. 
the normal human MS, we observed a significant component
of connective tissue, with perivascular fibroblasts surround-
ing the blood capillaries, and discrete collagen bundles (Fig. 
2c). Single or grouped adipocytes were associated with small 
blood capillaries or intermingled between the free cells of 
MS. In the normal rat omental MS, leukocytes were also 
seen; these were mainly neutrophils, but there were occasional 
eosinophillic cells as well. Single or small groups (3-5 cells) 
of erythrocytes were observed in some instances in the rat. 
We also saw large rounded cells rich in ribosomes and with a 
large nucleus, around the blood vessels. They appeared to be 
immature fibroblasts or mesenchymal cells. Endothelial cells
with well developed caveolar system rested over basal lamina 
and formed capillaries with rounded lumens (Fig. 2c). Large 
lymphatic vessels of the "cysterna-like" type were often located 
in the vicinity of the mesothelium. Single fibers or fine collagen
bundles were disposed between them. The lymphatic vessels 
possessed extremely flat lumens and were located with their
wide diameter parallel to the peritoneal surface of the greater 
omentum. The lymphatic endothelial cells were extremely thin, 
electron-lucent, displayed a rich caveolar system, and having 
no basal lamina. 
EXTRAOMENTAL MILKY SPOTS
MS were also described on the parietal peritoneum over the 
pancreas in the mouse (104). These spots were the same in 
structural details as the omental MS. Far more interesting are 
the so called splenoportal MS, also described in mice (31). 
They are present in the fat bands along the splenic artery. There 
are sporadic aberrant spleens and numerous MS, supplied 
with offshoots of the splenic artery. The splenoportal MS are 
composed of abundant lymphocytes with macrophages, plasma 
cells, granulocytes, megakaryocytes and various stromal cells. 
They show active neutrophilic myelopoiesis and probable 
megakaryopoiesis. The morphological transition from aber-
rant spleens via transitional forms to splenoportal MS seems 
to indicate that splenoportal MS represent splenoid lymphoid 
tissues (31). The presence of MS on the peritoneum covering 
the Douglas pouch (excavatio rectouterina, cavum Douglasi) 
was reported recently (105).
 MS are present also in other serous membranes: pleura 
and pericardium. Kampmeier (106) encountered plaques of 
macrophages in the mediastinal pleura behind the heart of a 
human baby. These were called by other authors “Kampmeier’s 
foci” (reviewed in 19, 107). Trypan blue or India ink injec-
tion into the pleural cavity of rats leads to its clear labeling 
by the injected dyes and the MS of the pleura were therefore 
nominated “macrophagal foci” (108). Other authors studied 
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opmental types of MS can be distinguished: “primary”, “pas-
sive”, and “active” (52). The “primary” MS are to be found 
only in fetuses and newborns (52,55). They contain a large 
quantity of undifferentiated mesenchymal cells, occasional 
fibroblasts with long branching processes, and adipocytes 
are almost lacking (52, 54). The “passive” MS of the human 
fetus appear approximately at the sixth month of uterine life. 
The number of MS mesenchymal cells diminishes, while the 
number of adipocytes increases (52,117). It was repeatedly 
suggested (52,53,55,117) that the adipocytes possess a pro-
liferative ability, and can differentiate in active macrophages. 
Every irritation of the peritoneal cavity, such as mechanical or 
chemical injury, or bacterial inflammation, leads to MS reor-
ganization, and they are transformed in “active” MS (11,52). 
The human newborn babies possess completely developed 
In the vicinity of the mesothelial covering, as well as near to 
the lymphatic vessels and between the free cells, bundles of 
thin unmyelinated and occasional myelinated nerve fibers were
found. 
 We also observed MS-like structures on the mediastinal 
pleura of the cat (Fig. 3c). The main cell types were fibro-
blasts, macrophages, neutrophil and eosinophil leukocytes, and 
lymphocytes. They were surrounded by capillaries or larger 
vessels. The blood and lymphatic capillaries had roughly equal 
parts in the vessels supply of MS.
ONTOGENY OF THE MILKY SPOTS
The characteristic vascular network of MS differentiates in 
the middle of the intrauterine development (54). Three devel-
Figure 3. Extraomental MS-like formations. Broad ligament of the uterus in the rat (a, b), mediastinal pleura of the cat (c). 
a: A complex pattern over a MS-lke structure. Deep furrows (arrows) are surrounded by ridges (asterisks). The formation is 
covered by flat mesothelial cells (F). b: Macrophages (arrows), lymphatic capillary (Lc) and bundles of thin unmyelinated 
fibers (asterisks), surrounded by small collagen bundles. c: Free cells, fibroblasts (asterisks) and collagen bundles in vicinity
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pleural MS (106,112).
 There are interesting sex differences in the number and 
development of mouse MS (118). The omental MS were clas-
sified into two types. Type II MS are distributed on the dorsal
layer of the omentum, and they are more numerous in females 
than in males. These MS appear at first at 10 days of age, and
they gradually increase in number equally in both sexes until 
two months. After two months, however, the density of the 
spots is significantly greater in females than in males. In male
mice which have been gonadectomized at first month, type II
MS show remarcable increase in density. In conjunction, the 
administration of testosterone to female mice causes a decrease 
in the density of the spots. Thus, the presence of testosterone 
plays a major role in development of sex difference in mice 
MS (118).
 The density of humans MS is greatest in infancy and gradu-
ally decreases with age (19,33). In infancy, the average number 
of omental MS/cm2 is from 30 to 40. As surface area of greater 
omentum increases with body growth, the number becomes 
lower: about 20/cm2 at 1 year of age, 10/cm2 at 3 years of age. 
In children, the number of MS decreases to 3-5/cm2, and in 
adults the average number is approximately 2/cm2 (19, 33). 
 Krist et al (119) studied the development and the earliest 
forms of MS in the human greater omentum, with special at-
tention to the macrophage population. The authors examined 
specimens from fetuses of 20-40 weeks gestation, and from a 
newborn. They found that small accumulations of cells were 
present at 20 weeks of gestation, about 50% of which were 
monocytes/macrophages. With increasing gestational age, the 
number of cell clusters as well as their size increased signifi-
cantly. Starting at 29 weeks, vascularized clusters of cells were 
seen, and “true” MS were present at 35 weeks. A significant
increase in the persentage of mature macrophages was found 
in developing MS, whereas no activated macrophages were 
seen. The percentage of B- and T-lymphocytes found in the 
cell clusters and in MS increased significantly but did not
exceed 10% of the total number of cells. The promonocytes 
most probably mature locally in developing MS (119).
 MS were examined in the fetal lamb omentum by means of 
light and electron microscopy under normal conditions and af-
ter intraperitoneal carbon injection in utero (120). Rudimentary 
MS appeared at 72 days of gestation, and at 116 days of gesta-
tion, macrophages were detected immunohistochemically. At 
125 days, T cells appeared in MS, but B cells were absent. 
At 148 days of gestation (newborn), MS were noted as black 
spots because of aggregation of carbon laden macrophages. 
Thus, at birth the MS macrophages already possess phagocytic 
ability.
MILKY SPOTS IN PATHOLOGY
A single intraperitoneal injection of fetal calf serum in rats 
resulted in an increase in the number and size of MS, as 
well as in an influx of leukocytes (11). The intraperitoneal
administration of foreign bodies or substances is followed by 
acute inflammatory reaction in MS (2,11,29,121,122). Under
inflammatory conditions, leukocytes dramatically increase in
the connective tissue matrix of MS and on the omental surface 
(26,121-124). A decreased quantity of adipocytes is observed 
due to retransformation of “inactive” MS fat nodes in “active” 
secondary MS (52,125-128). There is mobilization of the fixed
mesenchymal cells in the active MS (52,129), and transforma-
tion of these cells in active phagocytes and macrophages that 
migrate towards the surface of the MS (2,129). They concen-
trate under the serous covering and phagocytise the foreign 
material (129). Certain particles of foreign material remain 
encapsulated in the omental MS forever (2,130,131).
 Weinberg et al (132) investigated the peritoneal plasma-
cytogenesis and polyploid transformation of mesenteric MS 
in mice infected by Shistosoma mansoni. The authors found 
a novel type, “specialized” MS, that are dedicated to active 
plasmacytogenesis and antibody secretion into the peritoneal 
cavity of the infected animals. Other researchers also studied 
the changes in mouse MS after infection by Schistosoma man-
soni (34). The activated MS displayed pronounced lymphocy-
tosis, plasmocytogenesis (IgM > IgG > IgA > Ig2a > IgG1), 
and myelomonocytosis. The lymphocytes were mainly of B1 
type (CD5/IgM+), with smaller number of T cells (positive 
for the T cell receptor/CD3/CD5 complex) and conventional 
B2 cells (B220/CD23+). Intraperitoneal injection of Bacil-
lus Calmette-Guerin (BCG) in rats, to study the reactivity of 
omental MS upon induction of a chronic immune response in 
the peritoneal cavity (25), increased the number of dendritic 
cells (133). During the first four months after BCG administra-
tion, the number and size of MS increased enormously. This 
was accompanied by formation of macrophage, T cell, and B 
cell areas, but interdigitating cells and follicular dendritic cells 
were not observed. The total number of cells in the peritoneal 
cavity also increased, and the cellular composition showed a 
strong similarity with MS. At the onset of experiments, bac-
teria were mostly observed in MS macrophages rather than 
in the draining lymph nodes. A cellular immune response 
was observed in parathymic lymph nodes but not in MS. The 
authors concluded that both unstimulated and stimulated MS 
should be regarded as perivascular infiltrates (25). They play
a role in the initial clearing of bacteria from the peritoneal 
cavity. Although the large increase in cell number is caused 
predominantly by immigration of cells, the results support 
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the role of MS as a site for local proliferation and maturation, 
especially in the case of macrophages and B cells. However, 
no support was found of the assumption that MS may function 
as a secondary lymphoid organ in the peritoneal cavity (25). 
 Doherty et al (134) studied plasma protein and leukocyte 
extravasation into the peritoneal cavity in mice and rats with 
experimental peritonitis, caused by injection of zymosan A. 
They found that omental MS were the only abdominal sites 
where intravenously administered Monastral Blue labeled 
interendothelial cell gaps responsible for plasma extravasa-
tion. The omentum was the only abdominal organ which 
showed an increase in blood flow during zymosan A-indiced
peritonitis. Further, the authors reported that omental MS are 
the major route through which leukocytes migrate into the 
peritoneal cavity, and that this process is carried out mainly by 
the postcapillary venules (134). Other researchers investigated 
the myelopoiesis in the omentum at normal and inflammatory
conditions (135). It was found that the increase in cells in the 
abdominal cavity in inflammation (schistosomal infection)
is due to the enhanced input and expansion of early myeloid 
progenitors sustaining the in situ production of abdominal cell 
populations, rather than to the input of systemic circulating 
inflammatory cells.
 The resolution of acute peritoneal inflammation requires
clearance of extravasated inflammatory cells. The neutrophils
undergo apoptosis and are ingested by macrophages (reviewed 
in 136). The inflammatory macrophages emigrate rapidly from
the peritoneal cavity to the draining lymph node during the 
resolution of inflammation, in contrast to the resident mac-
rophages, which persist in the noninflammed peritoneum for
weeks (137). Further, the macrophages adhere specifically to
mesothelium overlying draining lymphatics and their emigra-
tion rate is regulated by the state of macrophage activation 
through specific adhesion molecule regulation of macrophage-
mesothelium interactions (138). 
 The peritoneal dialysis is a life-saving procedure but it is not 
harmless. The mesothelial covering of the peritoneum and the 
submesothelial connective tissue layer are seriously altered and 
some patients develop sclerosing peritonitis (40,41,139-141). 
MS have an important role in this process (42-46). Garosi and 
Di Paolo (42,43) evaluated the number and size of omental 
MS in rats subjected to dialysis for 15, 30 and 60 days, and 
compared them with untreated animals. After 15 days of 
dialysis the number and mean size of MS were significantly
lower than in the control group. After 30 days of dialysis, 
values returned to a level similar to that in controls, and after 
60 days of dialysis, the values were significantly greater. The
early decrease seemed to be due to washing of the peritoneum 
and replacement of resident white cells at the expense of the 
white cell population in the MS. At 30 days, a process of 
adaptation aims to establish functional equilibrium, and the 
increase after 60 days of dialysis may be due to the chronic 
inflammatory stimulus of dialysis solutions with poor biocom-
patibility. In accordance with these data, rats with peritoneal 
dialysis for 10 weeks had significantly more MS and blood
vessels in the greater omentum, and electron-microscopic 
analysis demonstrated dramatic changes in the appearance of 
the MS vascular endothelial cells and a severely damaged or 
even absent mesothelium on the peritoneal membrane (44,46). 
A striking increase in number of mast cells in the rat omental 
MS was observed upon exposure to peritoneal dialysis fluid
(45). This increase is probably linked to neovascularization, 
since the mast cells can produce angiogenic factors.
 After direct stimulation with staphylococci, the human me-
sothelial cells produce the chemokine interleukin-8 (142,143). 
This response leads to an influx of neutrophils, which are
the most important eliminators of bacteria. In addition to 
neutrophils, mesothelial cells also can ingest bacteria (143). 
Upon bacterial inflammation, only a few staphylococci are
digested, but Escherichia coli are ingested on a much larger 
scale during the first 8 h, and then, after the mesothelial cells
disintegrate, a widespread proliferation of bacteria is observed. 
This difference in the reactivity of the mesothelial cells might 
explain why peritonitis caused by gram-negative bacteria, such 
as Escherichia coli, is clinically more severe than peritonitis 
caused by staphilococci (144). Both the peritoneal macro-
phages and mesothelial cells produce mediators involved in 
the control of inflammation. It has been widely accepted that
resident peritoneal macrophages form the first line of defence
against peritoneal infection, and a more contemporary view 
suggested that the direct or indirect (via secreted proinflam-
matory cytokines) interaction between peritoneal macrophages 
and mesothelial cells is pivotal to the activation of the perito-
neum response to infection (145). Mesothelial cells produce 
important chemokines, involved in peritoneal inflammation:
GRO-α (attractant for neutrophils), MCP-1 and RANTES 
(monocyte attractants) (146). This suggests an important role 
for mesothelial cells in host defense. The neutrophil leukocyte 
migration into the peritoneal cavity in response to peritonitis 
is an important mechanism of host defence against bacterial 
invasion, and the mast cells are especially necessary for neutro-
phils migration within the infected peritoneal cavity (147).
 We studied the omental MS in rats with experimental peri-
tonitis caused by intraperitoneal injection of Pseudomonas 
aeruginosa (Fig. 4a-f). The mesothelial covering over MS is 
built by activated mesothelial cells with numerous microvilli, 
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abundant dilated cisternae of the rough endoplasmic reticu-
lum, prominent Golgi complex, numerous lipid droplets and 
a rich caveolar system (Fig. 4a). Some mesothelial cells show 
degenerative changes in their organelles. At certain regions, 
the mesothelial cells have no basal lamina and are located su-
perficially towards the peritoneal cavity. The MS are disposed
close to the mesothelial row, and increase in size and number. 
The connective tissue components (adipocytes, fibroblasts and
collagen fibers) decrease in number, and are often missing. MS
are composed only of a larger number of free cells, separated 
by wider intercellular spaces (Fig. 4b). This is probably a result 
of an increased microvascular permeability to fluids and fibrin
and its deposits between the cells. The activated macrophages 
form large groups and are filled with secondary lysosomes.
The superficial location of the macrophages within the me-
sothelial layer is far more common than observed in healthy 
animals. At the investigated time intervals (days 5 and 8 after 
the intraperitoneal application of Pseudomonas aeruginosa), 
the quantity of lymphocytes appeared to be only slightly 
changed. They either occupied a position immediately under 
the mesothelial cells, or they form small groups in the center 
of the MS together with plasmocytes (Fig. 4c). The number 
of neutrophylic leukocytes was increased and they formed 
clusters that did not contain other cells (Fig. 4d). Numerous 
Figure 4. Omental milky spots in the rat with experimental peritonitis, caused by intraperitoneal instillation of Pseudomonas 
aeruginosa. a: Two lymphocytes (arrows) under activated mesothelial cells (m). b: Blood capillaries (arrows) and a large 
cluster of free cells, surrounded by wide intracellular spaces and collagen fibers. c: Lymphocytes (L), neutrophil leukocyte 
(N), macrophage (M) and portions of plasmocytes (arrows). d: Group of neutrophil leukocytes (N). e: Wide spaces between 
blood capillaries (asterisks). f: Blood capillaries (asterisks) and eosinophil leukocytes (arrows). a x 5000; b x 2500; c x 
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small capillaries without perivascular cells were also observed 
(Fig. 4e). A few mast cells and eosinophilic leukocytes were 
located in the vicinity of the capillaries (Fig. 4f). The number, 
shape and size of the lymphatic capillaries were comparable 
with those in normal MS. 
 Since the pioneer observations of Dux (7), the evidence of 
MS involvement in malignant processes is constantly growing. 
MS become hypertrophic and congested soon after intraperito-
neal inoculation of Ehrlich ascites tumor in rodents. This sug-
gests that MS are the targets for the formation of small omental 
nodules in the advanced stage of Ehrlich ascites tumors. The 
number of γ-globulin-producing cells in MS increases from 
the second day after inoculation with same tumor, reaching 
60-70% of the cells in MS after 9 days (148). Eight hours after 
intraperitoneal injection of WP1 tumor cells in rats, scattered 
tumor cells were attached to the surface of the MS (149), while 
24 hours after the injection the tumor cells on the surface of MS 
were numerous. The mesothelium was disrupted by an inflam-
matory response, suggesting that the attachment of tumor cells 
was linked to the host inflammatory response (149). Even fol-
lowing subcutaneous (not intraperitoneal) injection of asbestos 
fibers in mice, some were found in MS more than 442 days
after the injection (68). This appears to be of clinical impor-
tance since there are numerous communications that asbestos 
fibers contribute to the genesis of a highly malignant tumor,
mesothelioma (reviewed in 68,150-152). MS are also related 
to sarcoma dissemination: 6-12 hours after Yoshida sarcoma 
cell intraperitoneal inoculation, sarcoma cells were found in 
MS (153). MS contained an increased number of macrophages, 
lymphocytes and neutrophil leukocytes. The tumor cells pro-
liferated and formed tumor nodules with neovascularization 
in MS, which suggested the significance of the MS as early
targets for disseminated intraperitoneal sarcoma (153). Cancer 
cells in the human MS were also detected (19,83,154). 
 Investigation of the participation of omentum in the devel-
opment of tumors at sites of intraabdominal trauma (various 
types of surgical wounds) revealed that a significant reduction
in the "uptake" of tumor cells at trauma sites were observed 
when maximal amounts of omentral tissue was removed (155). 
Further, the stimulation of omental macrophages resulted in 
increased tumor growth on the omentum (156), suggesting that 
the macrophage activity in omental MS may lead to a secretion 
of growth factors enhancing the tumor growth (155). Similarly, 
secretion of angiogenic factors from the omentum may also 
result in early neovascularization of seeded tumor and more 
rapid growth (19,156-158). MS appear appropriate as a target 
organ in every phase of tumor cell metastasis (19,159-162). 
Cancer cells usually form clumps in the ascitic fluid (163),
and have a high chance of attaching to the omentum because 
omentum takes part in fluid drainage from the peritoneal cavity
(2,5,9,19,129,164-166). Exfoliation of mesothelial cells and 
basal lamina degradation appear to be essential steps for tumor 
cell infiltration (167,168). MS are easily infiltrated by tumor
cells as their surface is not completely covered by mesothe-
lial cells (2,7,9,19,26,37,53,73,169), which lack basal lamina 
(7,9,11,26,29, 53,70,105). Hagiwara et al (159) examined the 
site-specific implantation of cancer cells in peritoneal tissues
after an intraperitoneal inoculation of 105 P388 leukemia cells. 
Twenty-four hours after the inoculation, most cancer cells 
were implanted in the omentum followed by (in decreasing 
order) gonadal fat, mesenterium, posterior abdominal wall, 
stomach, liver, intestine, anterior abdominal wall, and lung. 
A significant correlation was established between the number
of infiltrating cancer cells and the number of MS. The same
authors examined the omentum after inoculation with leukemia 
cells labeled by  the DNA syntesis inicator bromodeoxyuridine 
(159). These tumor cells were found to be infiltrating only
MS, whereas none were seen at other omental sites. Thus, the 
tumor cells seeded intraperitoneally specifically infiltrate MS
in the early stage of peritoneal metastases. In support of this 
conclusion, three different mouse carcinomatous peritonitis 
models (using P388 leukemia cells, Colon26 cancer cells, 
and B16PC melanoma cells) showed that tumor cells prefer-
entially infiltrates MS as early as one day after the inoculation
(160,161). In a model investigating the peritoneal dissemina-
tion of pancreatic cancer cells in golden hamsters, the authors 
found that the cancer cells were easily absorbed at the omental 
MS and the diaphragmatic stomata, and lymphatic metastasis 
occurred four days after inoculation (170). However, on the 
parietal peritoneum the cancer cells proliferated in spots with 
exfoliated mesothelial cells and exposed basal lamina. This 
process was comparably more time-consuming, and accord-
ingly metastasis occurred at seven days after inoculation. 
Thus, two patterns of peritoneal dissemination of pancreatic 
cancer cells appeared: lymphatic and direct metastases (170). 
Evaluation of the metastatic pattern of CC531 colon carcinoma 
cells administered in the peritoneal cavity of rats revealed that 
tumor cells concentrated in omental MS within four hours 
after inoculation (169). The size of MS increased as a result 
of increased number of tumor cells and macrophages. After 
7-21 days, MS were completely replaced by tumor cells, and 
new MS were formed. The concentration of tumor cells in 
the omental MS was followed by the paracolic gutters, the 
subhepatic and subphrenic spaces and in the lymphatic lacunae 
of the diaphragm.
 Intraperitoneal immunotherapy has been widely used as an 
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adjuvant postsurgical treatment of intraperitoneal malignant 
diseases (171-175). This route of administration is anatomical-
ly appropriate because it directly introduces the drugs into the 
peritoneal cavity. Whereas the mechanisms of intraperitoneal 
immunotherapeutic activity have not been elucidated in detail, 
peritoneal macrophages are known to be an important effector 
cells in the host defence against tumors and metastases. In this 
regard, omental MS generating peritoneal macrophages could 
have important antitumor host defense activities (19,176). 
Recently, there is a growing understanding of the mechanisms 
that allow the tumor cells to evade the host immune system, 
and, morevover, to use inflammatory mechanisms to promote
tumor growth and spread inside the peritoneal cavity (177). 
The cytokine release was studied after the intraperitoneal 
administration of beta-1,3-D-polyglucose-treated microbeads 
(178). Numerous microbeads phagocytosed by MS macro-
phages were seen 48 h after administration, and significant
amounts of interleukin-1 and prostaglandin E2 were released 
from these macrophages. Intraperitoneal administration of a 
killed streptococcal preparation, OK-432, might prove to be an 
effective biological response modifier for managing malignant
ascites (172) by activating the MS macrophages (122). These 
cells demonstrated increased surface membrane activity and 
migration through MS “stomata” into the peritoneal cavity. 
The characteristic features of activated MS suggest that they 
are a valuable source of macrophages for intraperitoneal im-
munotherapy (19, 122). The penetration of tumor cells into 
MS was studied in mice after intraperitoneal, subcutaneous 
and intravenous injections, and then the tumoricidal activity 
of MS macrophages was analyzed (179). Tumor cells could 
be detected in MS within 10 min after intraperitoneal inocu-
lation. Macrophages isolated from MS of mice immunized 
against syngeneic as well as allogeneic tumor cells expressed 
a significant cytotoxicity, which preceded the cytotoxicity of
peritoneal macrophages. MS were infiltrated only by tumor
cells derived directly from the peritoneal cavity. These data 
support the view that immune reactions against intraperitone-
ally injected tumor cells are initiated in MS, and might lead 
to “peritoneal immunity” against these tumor cells (179). 
Other researchers investigated the effect of intraperitoneal 
administration of granulocyte/macrophage colony-stimulating 
factor (GMCSF) on omental MS composition and tumoricidal 
activity against syngeneic colon carcinoma cells in rats (180). 
The results of in vitro study showed that GMCSF treatment led 
to an increased cytotoxicity of omental macrophages against 
the tumor cell line. Further, the intraperitoneal administration 
of GMCSF for one week was associated with an increase of 
MS macrophage proliferation and an enhanced antitumor 
activity. Thus, the GMCSF treatment may prove beneficial
as local immunotherapy in the prevention of intraabdominal 
tumor growth (180). 
 The malignant mesothelioma remains an incurable disease, 
but some recent data have shown a potential for immunomodu-
latory therapies, such as exogenous cytokine administration. 
Intracavitary IFN-β gene therapy in mice using an adenoviral 
vector provided strong T cell-mediated antitumor effects in 
experimental models of mesothelioma, and suggested that 
this may be a promising strategy for the treatment of localized 
tumors such as mesothelioma or ovarian cancer in humans 
(181). Further, two days after the intraperitoneal injection of 
the adenoviral vector in mice with peritoneal tumors, an influx
of activated natural killer cells, polymorphonuclear leukocytes 
and macrophages was observed (182). Up to 10 days after 
application of the vector, a large influx of activated CD4- and 
CD8-positive T cells was present in both peritoneal fluid and
tumor nodules. The CD8-positive T cells exhibited an effective 
tumor cell killing. These authors concluded that the tumor-
specific T cells are key effector cells for tumor eradication.
CONCLUSION
MS are tiny tissue aggregates located mainly on the greater 
omentum, but also on other peritoneal regions, as well as 
on the pleura and the pericardium. They are composed of 
mesenchymal cells around blood capillaries and are covered 
incompletely with mesothelial cells. MS are involved in normal 
functions as well as in pathologic processes. Since the begin-
ning of the 20th century, the nomination of omental MS as 
“policeman of the abdomen” or “friend in need” was extended 
in numerous recent findings. While initially MS were identified
as structures which have the ability to phagocytose foreign 
bodies in the peritoneal cavity, they were later recognized also 
as lymphoid tissue that vigorously participates in the immune 
reactions of the serous cavities. Under inflammatory condi-
tions, MS act as the first line of defense in these cavities, and
are involved in extramedullary hematopoiesis. MS are an early 
target of intraperitoneal (intrapleural) tumor metastases, and 
thus are an important site in the development of an antitumor 
immune response. The modulation of this response holds a 
potential for improving the immunotherapeutic strategy against 
malignant diseases.
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